BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 27645494)

  • 1. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
    Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J
    Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Statin associated myopathy in clinical practice. Results of DAMA study].
    Millán J; Pedro-Botet J; Climent E; Millán J; Rius J
    Clin Investig Arterioscler; 2017; 29(1):7-12. PubMed ID: 27717598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
    Koro CE; Sowell MO; Stender M; Qizilbash N
    Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing statin-induced muscle toxicity in a lipid clinic.
    Blaier O; Lishner M; Elis A
    J Clin Pharm Ther; 2011 Jun; 36(3):336-41. PubMed ID: 21414023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-induced myopathies.
    Tomaszewski M; Stępień KM; Tomaszewska J; Czuczwar SJ
    Pharmacol Rep; 2011; 63(4):859-66. PubMed ID: 22001973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.
    Harris LJ; Thapa R; Brown M; Pabbathi S; Childress RD; Heimberg M; Braden R; Elam MB
    J Clin Lipidol; 2011; 5(4):299-307. PubMed ID: 21784376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features related to statin-associated muscle symptoms.
    Ochs-Balcom HM; Nguyen LM; Ma C; Isackson PJ; Luzum JA; Kitzmiller JP; Tarnopolsky M; Weisman M; Christopher-Stine L; Peltier W; Wortmann RL; Vladutiu GD
    Muscle Nerve; 2019 May; 59(5):537-543. PubMed ID: 30549046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype standardization for statin-induced myotoxicity.
    Alfirevic A; Neely D; Armitage J; Chinoy H; Cooper RG; Laaksonen R; Carr DF; Bloch KM; Fahy J; Hanson A; Yue QY; Wadelius M; Maitland-van Der Zee AH; Voora D; Psaty BM; Palmer CN; Pirmohamed M
    Clin Pharmacol Ther; 2014 Oct; 96(4):470-6. PubMed ID: 24897241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statin-associated muscle symptoms : Current management in 2018].
    Kosinski C; Tran C; Kuntzer T; Rodondi N; Collet TH
    Rev Med Suisse; 2018 Feb; 14(596):462-469. PubMed ID: 29489126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D.
    Riphagen IJ; van der Veer E; Muskiet FA; DeJongste MJ
    Curr Med Res Opin; 2012 Jul; 28(7):1247-52. PubMed ID: 22686958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D deficiency, myositis-myalgia, and reversible statin intolerance.
    Glueck CJ; Budhani SB; Masineni SS; Abuchaibe C; Khan N; Wang P; Goldenberg N
    Curr Med Res Opin; 2011 Sep; 27(9):1683-90. PubMed ID: 21728907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins, myalgia, and rhabdomyolysis.
    Tournadre A
    Joint Bone Spine; 2020 Jan; 87(1):37-42. PubMed ID: 30735805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of 160 cases of statin-induced myopathy].
    Jiang Y; Lou Y; Liu Y; Wang L; Pang H; Zhang J; Zhou Y; Li Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Nov; 42(11):905-9. PubMed ID: 25620251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and myotoxicity: a therapeutic limitation.
    Tiwari A; Bansal V; Chugh A; Mookhtiar K
    Expert Opin Drug Saf; 2006 Sep; 5(5):651-66. PubMed ID: 16907655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a safety initiative for patients on concomitant amiodarone and simvastatin therapy in a Veterans Affairs medical center.
    Karimi S; Hough A; Beckey C; Parra D
    J Manag Care Pharm; 2010 Sep; 16(7):472-81. PubMed ID: 20726676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin induced myotoxicity.
    Sathasivam S
    Eur J Intern Med; 2012 Jun; 23(4):317-24. PubMed ID: 22560377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin Associated Muscular Adverse Effects.
    Kammoun R; Charfi O; Lakhoua G; Zaiem A; Daghfous R; Kastalli S; Aouinti I; Aidli SE
    Curr Drug Saf; 2024; 19(1):114-116. PubMed ID: 36847228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.